EcoDrugPlus

Solute Carrier Family 6 Member 1a

Ensembl ID : ENSSMAG00000020940
Gene Symbol: SLC6A1A
1 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 1b

Ensembl ID : ENSSMAG00000014059
Gene Symbol: SLC6A1B
1 Cross references
209 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSSMAG00000008717
Gene Symbol: SLC6A2
3 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSSMAG00000003672
Gene Symbol: SLC6A3
1 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSSMAG00000000704
Gene Symbol: SLC6A4A
3 Cross references
201 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSSMAG00000015239
Gene Symbol: SLC6A9
3 Cross references
208 Possible Orthologues:

Somatostatin Receptor Type 2-Like

Ensembl ID : ENSSMAG00000005074
Gene Symbol: LOC118287884
2 Cross references
192 Possible Orthologues:

Somatostatin Receptor Type 2-Like

Ensembl ID : ENSSMAG00000017134
Gene Symbol: LOC118288984
2 Cross references
192 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSSMAG00000021163
Gene Symbol: LOC118313169
2 Cross references
183 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSSMAG00000007199
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSSMAG00000028642
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSSMAG00000006059
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).